Mr. David Walsh:

I may ask Mr. Goodman to comment on some of the issues in regard to who can act as a vaccinator and the regulatory environment around that. Pharmacists potentially have two critical roles within the overall process. One is that, for larger-scale clinics, pharmacists can add immensely to the efficiency of the operation of those clinics through their participation in the cold chain and, also, in the reconstitution of the vaccines prior to administration. Second, community pharmacy will definitely have a very large role in the overall roll-out of this programme. When we consider the numbers, although I do not have them in front of me, if there are nearly 500,000 people over the age of 70 in the country and our target for vaccination is ten times that figure, I think community pharmacy will have a huge role.